A Comprehensive research study conducted by KD Market
Research on Rapid
Tests Market Opportunity Analysis and Industry forecast. report
offers extensive and highly detailed historical, current and future market
trends in Rapid Tests Market. Rapid Tests Market report includes
market size, growth drivers, barriers, opportunities, trends and other
information which helps to find new opportunities in this market for the growth
of the business through new technologies and developments.
The global rapid tests market generated $21,455 million in
2016, and is projected to reach $39,103 million by 2023, growing at a CAGR of
8.9% from 2017 to 2023. Rapid tests are diagnostic assays designed for use
where preliminary screening tests need to be conducted. These tests are easy,
quick, and provide specific results; hence, are used in settings with limited
resources. Rapid tests are incorporated in diagnosis of different diseases and
health conditions such as HIV, influenza, malaria, cancer, pregnancy &
fertility, and others.
Request for sample@ https://www.kdmarketresearch.com/sample/3186
The rapid tests market is expected to grow at a significant
rate during the forecast period, owing to increase in awareness regarding early
diagnosis of disease, prevalence of infectious diseases, and need for low cost
as well as accurate diagnostic testing. In addition, growth in personalized
care and increased promotional activities by manufacturers encourage the usage rapid
tests, which further facilitate the growth of the market. However, stringent
government regulations for the approval of rapid tests and recall of several
products due to false results are expected to impede the market growth.
The global rapid tests market is segmented based on product,
application, end user, and region. Based on product, the market is bifurcated
into over-the-counter (OTC) rapid test product and professional rapid test
product. By application, the market is classified into infectious disease,
cardiology, oncology, pregnancy & fertility, toxicology, glucose
monitoring, and others. According to end user, it is segmented as hospital
& clinic, diagnostic laboratory, home care, and others. Based on region,
the market is studied across North America (U.S., Canada, and Mexico), Europe
(Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China,
Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA
(Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
·
The study provides an in-depth analysis of the
market along with current trends and future estimations to elucidate the
imminent investment pockets.
·
It offers a quantitative analysis from 2016 to
2023, which is expected to enable the stakeholders to capitalize on prevailing
market opportunities.
·
Comprehensive analysis of all geographical
regions is provided to determine the existing opportunities.
·
The profiles and growth strategies of key
players are thoroughly analyzed to understand the competitive outlook of the
global market.
KEY MARKET SEGMENTS
By Product
-Over-the-counter (OTC) Rapid Test Product
-Professional Rapid Test Product
-Professional Rapid Test Product
By Application
-Infectious Disease
-HPV
-Hepatitis
-Influenza
-Malaria
-HIV
-Others
-Cardiology
-Oncology
-Pregnancy & Fertility
-Toxicology
-Glucose Monitoring
-Others
-HPV
-Hepatitis
-Influenza
-Malaria
-HIV
-Others
-Cardiology
-Oncology
-Pregnancy & Fertility
-Toxicology
-Glucose Monitoring
-Others
By End User
-Hospital & Clinic
-Diagnostic Laboratory
-Home Care
-Others
-Diagnostic Laboratory
-Home Care
-Others
By Region
-North America
-U.S.
-Canada
-Mexico
-Europe
-Germany
France
-UK
-Italy
-Spain
-Rest of Europe
-Asia-Pacific
-Japan
-China
-Australia
-India
-South Korea
-Rest of Asia-Pacific
-LAMEA
-Brazil
-Saudi Arabia
-South Africa
-Rest of LAMEA
-U.S.
-Canada
-Mexico
-Europe
-Germany
France
-UK
-Italy
-Spain
-Rest of Europe
-Asia-Pacific
-Japan
-China
-Australia
-India
-South Korea
-Rest of Asia-Pacific
-LAMEA
-Brazil
-Saudi Arabia
-South Africa
-Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT- Akers
Biosciences, Inc., Alere Inc. (Abbott Laboratories, Becton, Dickinson and
Company, Bio-rad Laboratories, Inc., Cepheid, Inc., Hologic, Inc., Meridian
Bioscience, Inc., Ora Sure Technologies, Inc., Quidel Corporation, Roche
Diagnostics
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players
are not profiled in the report. The same will be included on request.)
-Abingdon Health
-ARKRAY, Inc.
-Biocom Diagnostics
-Biomerica, Inc.
-Demeditec Diagnostics GmbH
-Epitope Diagnostics Inc.
-NanoRepro AG.
-Randox Laboratories Ltd.
-ARKRAY, Inc.
-Biocom Diagnostics
-Biomerica, Inc.
-Demeditec Diagnostics GmbH
-Epitope Diagnostics Inc.
-NanoRepro AG.
-Randox Laboratories Ltd.
Access Complete Research Report with toc@ https://www.kdmarketresearch.com/report/3186/rapid-tests-market-amr
Table of Content
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Market Share Analysis
3.2.2. Market Share Analysis
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Benefits of endometrial ablation over hysterectomy
3.3.1.2. Advancement in endometrial ablation techniques
3.3.1.3. High number of menorrhagia affected population
3.3.1.4. Increase in healthcare expenditures worldwide
3.3.1.2. Advancement in endometrial ablation techniques
3.3.1.3. High number of menorrhagia affected population
3.3.1.4. Increase in healthcare expenditures worldwide
3.3.2. Restraint
3.3.2.1. Risk associated with endometrial ablation
3.3.3. Opportunities
3.3.3.1. Growth opportunities in emerging markets
3.3.3.2. Increase in demand for minimally invasive procedures
3.3.3.2. Increase in demand for minimally invasive procedures
3.3.4. Impact Analyses
CHAPTER 4: ENDOMETRIAL ABLATION DEVICES MARKET, BY
TECHNOLOGY
4.1. Overview
4.1.1. Market size and forecast
4.2. Radiofrequency Ablation
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Cryoablation
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Hydrothermal Ablation
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Thermal Balloon
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.6. Hysteroscopic Ablation
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
4.7. Others
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country
CHAPTER 5: ENDOMETRIAL ABLATION DEVICES MARKET, BY END
USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Ambulatory Surgical Center
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.2.2. Market analysis, by country
5.3. Clinics
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.3.2. Market analysis, by country
5.4. Hospitals
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.4.2. Market analysis, by country
CHAPTER 6: ENDOMETRIAL ABLATION DEVICES MARKET BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2. Market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. endometrial ablation devices market, by
technology type
6.2.2.1.2. U.S. endometrial ablation devices market, by end user
6.2.2.1.2. U.S. endometrial ablation devices market, by end user
6.2.2.2. Canada
6.2.2.2.1. Canada endometrial ablation devices market, by
technology type
6.2.2.2.2. Canada endometrial ablation devices market, by end user
6.2.2.2.2. Canada endometrial ablation devices market, by end user
6.2.2.3. Mexico
6.2.2.3.1. Mexico endometrial ablation devices market, by
technology type
6.2.2.3.2. Mexico endometrial ablation devices market, by end user
6.2.2.3.2. Mexico endometrial ablation devices market, by end user
6.2.3. North America endometrial ablation devices market, by
technology type
6.2.4. North America endometrial ablation devices market, by end user
6.2.4. North America endometrial ablation devices market, by end user
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany endometrial ablation devices market, by
technology type
6.3.2.1.2. Germany endometrial ablation devices market, by end user
6.3.2.1.2. Germany endometrial ablation devices market, by end user
6.3.2.2. France
6.3.2.2.1. France endometrial ablation devices market, by
technology type
6.3.2.2.2. France endometrial ablation devices market, by end user
6.3.2.2.2. France endometrial ablation devices market, by end user
6.3.2.3. UK
6.3.2.3.1. UK endometrial ablation devices market, by
technology type
6.3.2.3.2. UK endometrial ablation devices market, by end user
6.3.2.3.2. UK endometrial ablation devices market, by end user
6.3.2.4. Italy
6.3.2.4.1. Italy endometrial ablation devices market, by
technology type
6.3.2.4.2. Italy endometrial ablation devices market, by end user
6.3.2.4.2. Italy endometrial ablation devices market, by end user
6.3.2.5. Spain
6.3.2.5.1. Spain endometrial ablation devices market, by
technology type
6.3.2.5.2. Spain endometrial ablation devices market, by end user
6.3.2.5.2. Spain endometrial ablation devices market, by end user
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe endometrial ablation devices
market, by technology type
6.3.2.6.2. Rest of Europe endometrial ablation devices market, by end user
6.3.2.6.2. Rest of Europe endometrial ablation devices market, by end user
6.3.3. Europe endometrial ablation devices market, by
technology type
6.3.4. Europe endometrial ablation devices market, by end user
6.3.4. Europe endometrial ablation devices market, by end user
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country
6.4.2. Market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan endometrial ablation devices market, by
technology type
6.4.2.1.2. Japan endometrial ablation devices market, by end user
6.4.2.1.2. Japan endometrial ablation devices market, by end user
6.4.2.2. China
6.4.2.2.1. China endometrial ablation devices market, by
technology type
6.4.2.2.2. China endometrial ablation devices market, by end user
6.4.2.2.2. China endometrial ablation devices market, by end user
6.4.2.3. Australia
6.4.2.3.1. Australia endometrial ablation devices market, by
technology type
6.4.2.3.2. Australia endometrial ablation devices market, by end user
6.4.2.3.2. Australia endometrial ablation devices market, by end user
6.4.2.4. India
6.4.2.4.1. India endometrial ablation devices market, by
technology type
6.4.2.4.2. India endometrial ablation devices market, by end user
6.4.2.4.2. India endometrial ablation devices market, by end user
6.4.2.5. South Korea
6.4.2.5.1. South Korea endometrial ablation devices market,
by technology type
6.4.2.5.2. South Korea endometrial ablation devices market, by end user
6.4.2.5.2. South Korea endometrial ablation devices market, by end user
6.4.2.6. Rest of Asia-Pacific
6.4.2.6.1. Rest of Asia-Pacific endometrial ablation devices
market, by technology type
6.4.2.6.2. Rest of Asia-Pacific endometrial ablation devices market, by end user
6.4.2.6.2. Rest of Asia-Pacific endometrial ablation devices market, by end user
6.4.3. Asia-Pacific endometrial ablation devices market, by
technology type
6.4.4. Asia-Pacific endometrial ablation devices market, by end user
6.4.4. Asia-Pacific endometrial ablation devices market, by end user
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil endometrial ablation devices market, by
technology type
6.5.2.1.2. Brazil endometrial ablation devices market, by end user
6.5.2.1.2. Brazil endometrial ablation devices market, by end user
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia endometrial ablation devices market,
by technology type
6.5.2.2.2. Saudi Arabia endometrial ablation devices market, by end user
6.5.2.2.2. Saudi Arabia endometrial ablation devices market, by end user
6.5.2.3. South Africa
6.5.2.3.1. South Africa endometrial ablation devices market,
by technology type
6.5.2.3.2. South Africa endometrial ablation devices market, by end user
6.5.2.3.2. South Africa endometrial ablation devices market, by end user
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA endometrial ablation devices
market, by technology type
6.5.2.4.2. Rest of LAMEA endometrial ablation devices market, by end user
6.5.2.4.2. Rest of LAMEA endometrial ablation devices market, by end user
6.5.3. LAMEA endometrial ablation devices market, by
technology type
6.5.4. LAMEA endometrial ablation devices market, by end user
6.5.4. LAMEA endometrial ablation devices market, by end user
CHAPTER 7: COMPANY PROFILES
7.1. AEGEA Medical, Inc.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Product portfolio
7.1.4. Key strategic moves and developments
7.1.2. Company snapshot
7.1.3. Product portfolio
7.1.4. Key strategic moves and developments
7.2. Boston Scientific Corporation
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. Hologic, Inc.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. Idoman Teoranta
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Product portfolio
7.4.2. Company snapshot
7.4.3. Product portfolio
7.5. Medtronic Plc. (Smith & Nephew Plc.)
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. Minerva Surgical, Inc.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Product portfolio
7.6.4. Key strategic moves and developments
7.6.2. Company snapshot
7.6.3. Product portfolio
7.6.4. Key strategic moves and developments
7.7. Olympus Corporation
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. Omnitech Systems, Inc.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.9. The Cooper Companies, Inc. (CooperSurgical, Inc.)
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.10. Veldana Medical SA
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. product portfolio
7.10.2. Company snapshot
7.10.3. product portfolio
Check Exclusive Discount on this Report @ https://www.kdmarketresearch.com/discount/3186
About Us:
KD Market Research is one of the best market research
organization that provides B2B research on the growth opportunities of the
industry which is the prime factor of the overall revenue of the organization.
We identify the pain points which our client is facing around revenue methods
and provide them with a comprehensive database which helps them to make
intelligent decisions that could ensure growth to the organization.
Our Services include market intelligence, competitive
intelligence, and customized research. These research reports help the
organizations to make quick and powerful decisions that make out highest growth
in revenue.
Contact us -
KD Market Research
150 State Street, Albany,
New York, USA 12207
Website: www.kdmarketresearch.com
Email id- sales@kdmarketresearch.com
No comments:
Post a Comment